Assessment of Immunogenicity, Safety and Reactogenicity of a Booster Dose of Various COVID-19 Vaccine Platforms in Individuals Primed With Several Regimes. (clinicaltrials.gov) - Apr 13, 2023 - P3 | N=760 | Active, not recruiting | Sponsor: D'Or Institute for Research and Education
New P3 trial • Real-world • Real-world evidence • Infectious Disease • Novel Coronavirus Disease
|